- Appreciate the controversies regarding the immune vs islet pathogenesis of type 1 diabetes.
- Recognize new perspectives on residual beta cells in type 1 diabetes.
- Appreciate the rationale underlying new approaches for the treatment of type 1 diabetes
04/01/2022 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Raghu Mirmira, MD, PhD